BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marra S, Arnaldi D, Nobili L. The pharmacotherapeutic management of obstructive sleep apnea. Expert Opinion on Pharmacotherapy 2019;20:1981-91. [DOI: 10.1080/14656566.2019.1652271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Doherty R, Madigan SM, Nevill A, Warrington G, Ellis JG. The Sleep and Recovery Practices of Athletes. Nutrients 2021;13:1330. [PMID: 33920560 DOI: 10.3390/nu13041330] [Reference Citation Analysis]
2 He L, Lin Z. An Exploratory Study on the Treatment of Obstructive Apnea-Hypopnea Syndrome by Nasal Cavity Expansion. J Healthc Eng 2021;2021:6926509. [PMID: 34804458 DOI: 10.1155/2021/6926509] [Reference Citation Analysis]
3 Schütz SG, Dunn A, Braley TJ, Pitt B, Shelgikar AV. New frontiers in pharmacologic obstructive sleep apnea treatment: A narrative review. Sleep Med Rev 2021;57:101473. [PMID: 33853035 DOI: 10.1016/j.smrv.2021.101473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fietze I, Blum H, Grüger H, Käßner F, Maurer JT, Nilius G, Penzel T, Triché D, Arzt M. Diagnostik und Therapie der residualen Tagesschläfrigkeit bei Patienten mit therapierter obstruktiver Schlafapnoe. Somnologie 2021;25:99-109. [DOI: 10.1007/s11818-021-00305-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]